The United States has experienced a resurgence of measles cases in recent years, driven by vaccine hesitancy and declining immunization rates in certain communities. As of mid-April 2026, the CDC has tracked over 1,400 confirmed measles cases, with outbreaks concentrated in urban and rural areas with lower vaccination coverage. The threshold of 1,800 cases represents a significant escalation from current levels—a roughly 30% increase over the next two weeks would be needed to cross this mark. Current market odds at 61% YES suggest traders believe additional outbreaks or case discovery in the remaining days of April is more likely than a plateau. Measles is a highly contagious disease spread through respiratory droplets, making it notoriously difficult to contain once it emerges in under-vaccinated populations. The CDC issues real-time case counts, and this market resolves based on officially reported confirmed cases. Recent trajectory shows steady growth, though the rapid rate needed to reach 1,800 would require sustained outbreak conditions. The current price reflects moderate conviction that case counts will continue their upward trend through month-end, though some risk remains that improvements in case isolation or vaccination clinics could slow transmission.